Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The present work aims to evaluate the presence of stromal tumour-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PDL1) expression in breast carcinomas and their correlation with available clinicopathological features.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Clin. Pathol.

Title: Journal of clinical pathology

Publisher: BMJ

ISSN (Electronic): 1472-4146

ISSN (Print): 0021-9746

Publication date (Electronic): Oct 2017

Volume: 70

Issue: 10

Affiliations

[1 ] Epithelial Interactions in Cancer (EPIC), i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal.

[2 ] Ipatimup, Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.

[3 ] Department of Pathology, Ipatimup Diagnostics, Ipatimup, University of Porto, Porto, Portugal.

[4 ] FMUP, Faculty of Medicine, University of Porto, Porto, Portugal.

[5 ] Complexo Hospitalar Universitario de Vigo (CHUVI), Vigo, Spain.

[6 ] Laboratoire National de Santé, Dudelange, Luxembourg.

Article

Publisher Item ID: jclinpath-2016-203990

DOI: 10.1136/jclinpath-2016-203990

PubMed ID: 28373294

SO-VID: d4cb8326-7ea0-4c95-85cc-2b23fc130c5f

History

Keywords: CANCER STEM CELLS,TUMOUR IMMUNITY,BREAST CANCER,TUMOUR MARKERS

Data availability:

Keywords: CANCER STEM CELLS, TUMOUR IMMUNITY, BREAST CANCER, TUMOUR MARKERS

Comments

Comment on this article

scite_

Cited by 20

See all cited by